CUE analyst estimates

Cue Biopharma (CUE) analyst ratings, the average price target and its range, and every firm's latest call.

CUE analyst ratings and price targets

DateFirmCallTarget
Oct 1, 2026B.Riley FinancialB.Riley Reiterates Buy Rating on Cue Biopharma (CUE)$83.00
Nov 15, 2024JefferiesCue Biopharma (CUE) PT Lowered to $4 at Jefferies$4.00
Jul 26, 2024JMP SecuritiesCue Biopharma price target lowered to $2 from $15 at JMP Securities$2.00
Mar 13, 2024JefferiesJefferies Starts Cue Biopharma (CUE) at Buy, 'Following Nature's "Cues" W/ Targeted IL-2 Therapy'$6.00
Nov 20, 2022Piper SandlerCue Biopharma initiated with an Overweight at Piper Sandler$7.00

Updated 2026-11-18 05:48 UTC